News
-
-
-
PRESS RELEASE
Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year
Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year. Successful clinical development enhances Formycon's position in biosimilars -
-
-
-
-
-
PRESS RELEASE
Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma announce strategic manufacturing partnership for biosimilars, enhancing global access to high-quality, affordable biologics. Collaboration between Formycon and OneSource strengthens supply capabilities and manufacturing expertise -